Accordingly, multiple studies have demonstrated elevation of C5a and sC5b-9 in patients with COVID-19 (15, 23, 24), as well as deposition of activated complement proteins in injured tissues and organs (25, 26). This evidence concerns the gene C5 and COVID-19.